An Effectiveness-implementation Hybrid Study of Social Prescribing in a Singapore Community Hospital Setting

NCT04840420 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 804

Last updated 2021-04-12

No results posted yet for this study

Summary

This research is an effectiveness-implementation hybrid study with two aims:

1\) to determine the utility of a WBC (Well Being Coordinator)-driven Social Prescribing model in the intermediate care setting;

and 2) to assess the patient health outcomes associated with the implementation pilot.

The implementation research questions include:

1. Practical fit: Does the intervention fit with the daily life activities of study participants? What is the level of safety and burdensomeness of the frequency, intensity and duration of the intervention?
2. Acceptability: What are the acceptance, retention and follow-up rates as the participants move through the intervention? What are the reasons for retention?
3. Adoption: How well do the WBC carry out the assessment and intervention as planned?

The key hypotheses include:

1. Participants in the intervention group will incur a higher improvement in perceived general wellbeing and social support than those participants in the control group.
2. Participants in the intervention group will incur less healthcare utilisation than those in the control group.
3. Improvement in the perceived general wellbeing and social support will be moderated by the level of social support of participants.

Conditions

  • Social Isolation

Interventions

OTHER

social prescribing

as above

OTHER

usual care

as above

Sponsors & Collaborators

  • Sengkang Community Hospital

    collaborator UNKNOWN
  • Outram Community Hospital

    collaborator UNKNOWN
  • Bright Vision Hospital

    lead OTHER

Principal Investigators

  • Lee Kheng Hock, MBBS · Bright Vision Hospital

  • Low Sher Guan, MBBS · Sengkang Community Hospital

  • Low Lian Leng, MBBS · Outram Community Hospital

  • Kwan Li Feng, Adeline · Sengkang Community Hospital

  • Zhao Dan · Sengkang Community Hospital

  • Wong Peng Yong, Andrew, MBBS · Bright Vision Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2022-09-30
Completion
2022-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04840420 on ClinicalTrials.gov